The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Regulatory Role of Nitric Oxide in Cutaneous Inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, excessively high NO levels can also indicate cellular stress or inflammation”
From Antimicrobial Composite Films Based on Alginate–Chitosan with Honey, Propolis, Royal Jelly and Green-Synthesized Silver Nanoparticles (2025) · cites this paper as [62]
In the citing paper
“Elevated NO production suggests enhanced immune activation, which can contribute to antimicrobial defense and wound healing.”
From Antimicrobial Composite Films Based on Alginate–Chitosan with Honey, Propolis, Royal Jelly and Green-Synthesized Silver Nanoparticles (2025) · cites this paper as [62]
In the citing paper
“nitric oxide plays a crucial role in immune defense, inflammation and tissue repair”
From Antimicrobial Composite Films Based on Alginate–Chitosan with Honey, Propolis, Royal Jelly and Green-Synthesized Silver Nanoparticles (2025) · cites this paper as [62]
In the citing paper
“so the balance observed in AMAg might be desirable for applications where controlled immune modulation is needed [62].”
From Antimicrobial Composite Films Based on Alginate–Chitosan with Honey, Propolis, Royal Jelly and Green-Synthesized Silver Nanoparticles (2025) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide synthases in mammals
Knowles, R. G., & Moncada, S. (1994) · Biochemical Journal · doi:10.1042/bj2980249 · Cited by 2,752
Nitric oxide in immunity and inflammation
Coleman, J. W. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00086-8 · Cited by 945
The Effect of Nitric-Oxide-Related Supplements on Human Performance
Bescós, R., Sureda, A., Tur, J. A., & Pons, A. (2012) · Sports Medicine · doi:10.2165/11596860-000000000-00000 · Cited by 231
Regulation of type 17 helper T-cell function by nitric oxide during inflammation
Niedbala, W., Alves-Filho, J. C., Fukada, S. Y., Vieira, S. M., Mitani, A., Sonego, F., Mirchandani, A., Nascimento, D. C., Cunha, F. Q., & Liew, F. Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100667108 · Cited by 117
Research works printed but not linked: 131
- Massion, P.B., O. Feron, C. Dessy, and J.L. Balligand. 2003. Nitric oxide and cardiac function: Ten years after, and continuing. Circulation Research 93 (5): 388–398. · DOI · Paper page
- Musialek, P., M. Lei, H.F. Brown, D.J. Paterson, and B. Casadei. 1997. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f). Circulation Research 81 (1): 60–68. · DOI · Paper page
- Shesely, E.G., N. Maeda, H.S. Kim, K.M. Desai, J.H. Krege, V.E. Laubach, P.A. Sherman, W.C. Sessa, and O. Smithies. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the USA 93 (23): 13176–13181. · DOI · Paper page
- Miyamoto, Y., Y. Saito, N. Kajiyama, M. Yoshimura, Y. Shimasaki, M. Nakayama, S. Kamitani, M. Harada, M. Ishikawa, K. Kuwahara, E. Ogawa, I. Hamanaka, N. Takahashi, T. Kaneshige, H. Teraoka, T. Akamizu, N. Azuma, Y. Yoshimasa, T. Yoshimasa, H. Itoh, I. Masuda, H. Yasue, and K. Nakao. 1998. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1): 3–8. · DOI · Paper page
- Cau, S.B., F.S. Carneiro, and R.C. Tostes. 2012. Differential modulation of nitric oxide synthases in aging: Therapeutic opportunities. Frontiers in Physiology 3: 218.
- Liu, Y.H., O.A. Carretero, O.H. Cingolani, T.D. Liao, Y. Sun, J. Xu, L.Y. Li, P.J. Pagano, J.J. Yang, and X.P. Yang. 2005. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology 289: H2616–H2623. · DOI
- Iwakiri, Y., and M.Y. Kim. 2015. Nitric oxide in liver diseases. Trends in Pharmacological Sciences 36 (8): 524–536. · DOI · Paper page
- Mahmoud, M.F., S. Zakaria, and A. Fahmy. 2015. Can chronic nitric oxide inhibition improve liver and renal dysfunction in bile duct ligated rats? Advances in Pharmacological Sciences 2015:298792. · doi:10.1155/2015/298792
- Weinberger, B., D.E. Heck, D.L. Laskin, and J.D. Laskin. 1999. Nitric oxide in the lung: Therapeutic and cellular mechanisms of action. Pharmacology & Therapeutics 84 (3): 401–411. · DOI
- Kinsella, J.P., T.A. Parker, H. Galan, B.C. Sheridan, A.C. Halbower, and S.H. Abman. 1997. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatric Research 41 (4 Pt 1): 457–463. · doi:10.1203/00006450-199704000-00002
- Kozłowska, Z., Z. Owsiańska, J.P. Wroblewska, et al. 2020. Genotype-phenotype correlation in two Polish neonates with alveolar capillary dysplasia. BMC Pediatrics 20 (1): 320. · doi:10.1186/s12887-020-02200-y
- Ramirez, L.A., E.E. Gillis, J.B. Musall, R. Mohamed, E. Snyder, A. El-Marakby, and J.C. Sullivan. 2020. Hypertensive female Sprague-Dawley rats require an intact nitric oxide synthase system for compensatory increases in renal regulatory T cells. American Journal of Physiology Renal Physiology 319 (2): F192–F201. · DOI
- Brinson, K.N., A.A. Elmarakby, A.J. Tipton, G.R. Crislip, T. Yamamoto, B. Baban, and J.C. Sullivan. 2013. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 305 (7): R701–R710.
- Zhan, R., S. Yang, W. He, F. Wang, J. Tan, J. Zhou, S. Yang, Z. Yao, J. Wu, and G. Luo. 2015. Nitric oxide enhances keratinocyte cell migration by regulating Rho GTPase via cGMP-PKG signalling. PLoS One 10(3):e0121551. · DOI
- Malone-Povolny, M.J., S.E. Maloney, and M.H. Schoenfisch. 2019. Nitric oxide therapy for diabetic wound healing. Advanced Healthcare Materials 8(12):e1801210. · DOI · Paper page
- Witte, M.B., T. Kiyama, and A. Barbul. 2002. Nitric oxide enhances experimental wound healing in diabetes. British Journal of Surgery 89 (12): 1594–1601. · DOI · Paper page
- Shi, H.P., S.M. Wang, G.X. Zhang, Y.J. Zhang, and A. Barbul. 2007. Supplemental L-arginine enhances wound healing following trauma/hemorrhagic shock. Wound Repair Regen. 15 (1): 66–70. · doi:10.1111/j.1524-475x.2006.00186.x
- Krischel, V., D. Bruch-Gerharz, C. Suschek, K.D. Kröncke, T. Ruzicka, and V. Kolb-Bachofen. 1998. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. The Journal of Investigative Dermatology 111 (2): 286–291. · DOI · Paper page
- Kitano, T., H. Yamada, M. Kida, Y. Okada, S. Saika, and M. Yoshida. 2017. Impaired healing of a cutaneous wound in an inducible nitric oxide synthase-knockout mouse. Dermatology Research and Practice 2017: 2184040. · DOI
- Dang, E., G. Man, J. Zhang, D. Lee, T.M. Mauro, P.M. Elias, and M.Q. Man. 2020. Inducible nitric oxide synthase is required for epidermal permeability barrier homeostasis in mice. Experimental Dermatology 29 (10): 1027–1032. · DOI
- Man, M.Q., J.S. Wakefield, T.M. Mauro, and P.M. Elias. 2021. Role of nitric oxide in regulating epidermal permeability barrier function. Experimental Dermatology https://doi.org/10.1111/exd.14470 · DOI
- Mihu, M.R., U. Sandkovsky, G. Han, J.M. Friedman, J.D. Nosanchuk, and L.R. Martinez. 2010. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence. 1 (2): 62–67. · DOI
- Martinez, L.R., G. Han, M. Chacko, M.R. Mihu, M. Jacobson, P. Gialanella, A.J. Friedman, J.D. Nosanchuk, and J.M. Friedman. 2009. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. The Journal of Investigative Dermatology 129: 2463–2469. · DOI · Paper page
- Ghaffari, A., R. Jalili, M. Ghaffari, C. Miller, and A. Ghahary. 2007. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen. 15: 368–377. · DOI
- Wallace, J.L. 2005. Nitric oxide as a regulator of inflammatory processes. Memorias do Instituto Oswaldo Cruz 100: S5-9. · DOI
- Moilanen, E., and H. Vapaatalo. 1995. Nitric oxide in inflammation and immune response. Annals of Medicine 27 (3): 359–367. · DOI · Paper page
- Medeiros, R., C.P. Figueiredo, G.F. Passos, and J.B. Calixto. 2009. Reduced skin inflammatory response in mice lacking inducible nitric oxide synthase. Biochemical Pharmacology 78 (4): 390–395. · DOI
- Stuehr, D., S. Pou, and G.M. Rosen. 2001. Oxygen reduction by nitric-oxide synthases. Journal of Biological Chemistry 276 (18): 14533–14536. · DOI · Paper page
- Förstermann, U., and W.C. Sessa. 2012. Nitric oxide synthases: regulation and function. European Heart Journal 33(7):829–37, 837a-837d. · DOI · Paper page
- Förstermann, U., and H. Kleinert. 1995. Nitric oxide synthase: Expression and expressional control of the three isoforms. Naunyn-Schmiedeberg’s Archives of Pharmacology 352 (4): 351–364. · DOI · Paper page
- Mattila, J.T., and A.C. Thomas. 2014. Nitric oxide synthase: Non-canonical expression patterns. Frontiers in Immunology 5: 478. · DOI · Paper page
- Jianjun Yang, J., R. Zhang, G. Lu, Y. Shen, L. Peng, C. Zhu, M. Cui, W. Wang, P. Arnaboldi, M. Tang, M. Gupta, C.F. Qi, P. Jayaraman, H. Zhu, B. Jiang, S.H. Chen, J.C. He, A.T. Ting, M.M. Zhou, V.K. Kuchroo, H.C. Morse 3rd., K. Ozato, A.G. Sikora, and H. Xiong. 2013. T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. Journal of Experimental Medicine 210 (7): 1447–1462. · DOI
- Gilchrist, M., S.D. McCauley, and A.D. Befus. 2004. Expression, localization, and regulation of NOS in human mast cell lines: Effects on leukotriene production. Blood 104 (2): 462–469. · DOI
- Devika, N.T., and B.M. Jaffar Ali. 2013. Analysing calcium dependent and independent regulation of eNOS in endothelium triggered by extracellular signaling events. Molecular BioSystems 9: 2653–2664. · DOI
- Förstermann, U., J.P. Boissel, and H. Kleinert. 1998. Expressional control of the “constitutive” isoforms of nitric oxide synthase (NOS I and NOS III). The FASEB Journal 12 (10): 773–790. · DOI · Paper page
- Herdegen, T., S. Brecht, B. Mayer, J. Leah, W. Kummer, R. Bravo, and M. Zimmermann. 1993. Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. Journal of Neuroscience 13 (10): 4130–4145. · DOI · Paper page
- Villar, M.J., S. Ceccatelli, K. Bedecs, T. Bartfai, D. Bredt, S.H. Synder, T Hökfelt. 1994. Upregulation of nitric oxide synthase and galanin message-associated peptide in hypothalamic magnocellular neurons after hypophysectomy. Immunohistochemical and in situ hybridization studies. Brain Research 650(2):219–28. · DOI
- Zhang, Z.G., M. Chopp, S. Gautam, C. Zaloga, R.L. Zhang, H.H. Schmidt, J.S. Pollock, and U. Förstermann. 1994. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Research 654 (1): 85–95. · DOI · Paper page
- Boissel, J.P., D. Ohly, M. Bros, U. Gödtel-Armbrust, U. Förstermann, and S. Frank. 2004. The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes. The Journal of Investigative Dermatology 123 (1): 132–139. · DOI
- Kaku, Y., H. Nanri, T. Sakimura, K. Ejima, A. Kuroiwa, and M. Ikeda. 1997. Differential induction of constitutive and inducible nitric oxide synthases by distinct inflammatory stimuli in bovine aortic endothelial cells. Biochimica et Biophysica Acta 1356 (1): 43–52. · DOI
- Bucher, M., K.P. Ittner, M. Zimmermann, K. Wolf, J. Hobbhahn, and A. Kurtz. 1997. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Letters 412 (3): 511–514. · DOI
- Neugarten, J., Q. Ding, A. Friedman, J. Lei, and S. Silbiger. 1997. Sex hormones and renal nitric oxide synthases. Journal of the American Society of Nephrology 8 (8): 1240–1246. · DOI
- Lantin-Hermoso, R.L., C.R. Rosenfeld, I.S. Yuhanna, Z. German, Z. Chen, and P.W. Shaul. 1997. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. American Journal of Physiology 273 (1 Pt 1): L119–L126.
- Ikeyama, K., S. Denda, M. Tsutsumi, and M. Denda. 2010. Neuronal nitric oxide synthase in epidermis is involved in cutaneous circulatory response to mechanical stimulation. The Journal of Investigative Dermatology 130 (4): 1158–1166. · doi:10.1038/jid.2009.350
- Zhang, B., W. Crankshaw, R. Nesemeier, J. Patel, I. Nweze, J. Lakshmanan, and B.G. Harbrecht. 2015. Calcium-mediated signaling and calmodulin-dependent kinase regulate hepatocyte-inducible nitric oxide synthase expression. Journal of Surgical Research 193 (2): 795–801. · DOI
- Pautz, A., J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert. 2010. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23 (2): 75–93. · DOI · Paper page
- Arany, I., M.M. Brysk, H. Brysk, and S.K. Tyring. 1996. Induction of iNOS mRNA by interferon-gamma in epithelial cells is associated with growth arrest and differentiation. Cancer Letters 110 (1–2): 93–96. · doi:10.1016/s0304-3835(96)04476-x
- Linehan, J.D., G. Kolios, V. Valatas, D.A. Robertson, and J. Westwick. 2005. Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells. Free Radical Biology & Medicine 39 (12): 1560–1569. · doi:10.1016/j.freeradbiomed.2005.07.019
- Taub, D.D., and G.W. Cox. 1995. Murine Th1 and Th2 cell clones differentially regulate macrophage nitric oxide production. Journal of Leukocyte Biology 58 (1): 80–89. · DOI
- Saha, R.N., and K. Pahan. 2006. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxidants & Redox Signaling 8 (5–6): 929–947. · DOI · Paper page
- Wienerroither, S., I. Rauch, F. Rosebrock, A.M. Jamieson, J. Bradner, M. Muhar, J. Zuber, M. Müller, and T. Decker. 2014. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins. Molecular and Cellular Biology 34 (3): 415–427. · DOI
- Holliman, G., D. Lowe, H. Cohen, S. Felton, and K. Raj. 2017. Ultraviolet radiation-induced production of nitric oxide: A multi-cell and multi-donor analysis. Science and Reports 7 (1): 11105. · DOI
- Chang, H.R., D.A. Tsao, S.R. Wang, and H.S. Yu. 2003. Expression of nitric oxide synthases in keratinocytes after UVB irradiation. Archives of Dermatological Research 295 (7): 293–296. · DOI
- Rafa, H., H. Saoula, M. Belkhelfa, O. Medjeber, I. Soufli, R. Toumi, Y. de Launoit, O. Moralès, M. Nakmouche, N. Delhem, and C. Touil-Boukoffa. 2013. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: Immunomodulatory effect of retinoic acid. Journal of Interferon and Cytokine Research 33 (7): 355–368. · DOI
- Rafa, H., M. Amri, H. Saoula, M. Belkhelfa, O. Medjeber, A. Boutaleb, S. Aftis, M. Nakmouche, and C. Touil-Boukoffa. 2010. Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: A study in Algerian patients. Journal of Interferon and Cytokine Research 30 (9): 691–697. · DOI
- Kankuri, E., K. Vaali, R.G. Knowles, M. Lähde, R. Korpela, H. Vapaatalo, and E. Moilanen. 2001. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. Journal of Pharmacology and Experimental Therapeutics 298 (3): 1128–1132.
- Kankuri, E., M. Hämäläinen, M. Hukkanen, P. Salmenperä, E. Kivilaakso, H. Vapaatalo, and E. Moilanen. 2003. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scandinavian Journal of Gastroenterology 38 (2): 186–192. · DOI
- Demirel, I., R. Vumma, C. Mohlin, L. Svensson, S. Säve, and K. Persson. 2012. Nitric oxide activates IL-6 production and expression in human renal epithelial cells. American Journal of Nephrology 36 (6): 524–530. · DOI
- Raykova, V.D., M. Glibetic, J.P. Ofenstein, and J.V. Aranda. 2003. Nitric oxide-dependent regulation of pro-inflammatory cytokines in group B streptococcal inflammation of rat lung. Annals of Clinical and Laboratory Science 33 (1): 62–67.
- Holán, V., M. Krulová, A. Zajícová, and J. Pindjáková. 2002. Nitric oxide as a regulatory and effector molecule in the immune system. Molecular Immunology 38 (12–13): 989–995. · DOI
- Hsu, C.C., C.L. Lin, I.M. Jou, P.H. Wang, and J.S. Lee. 2017. The protective role of nitric oxide-dependent innate immunosuppression in the early stage of cartilage damage in rats: Role of nitric oxide in cartilage damage. Bone & Joint Research 6 (4): 253–258. · DOI
- Bécherel, P.A., M.D. Mossalayi, F. Ouaaz, L. Le Goff, B. Dugas, N. Paul-Eugène, C. Frances, O. Chosidow, E. Kilchherr, J.J. Guillosson, et al. 1994. Involvement of cyclic AMP and nitric oxide in immunoglobulin e-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. The Journal of Clinical Investigation 93 (5): 2275–2279. · DOI
- Chun, K.S., H.H. Cha, J.W. Shin, H.K. Na, K.K. Park, W.Y. Chung, and Y.J. Surh. 2004. Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 25 (3): 445–454. · DOI
- Ianaro, A., C.A. O’Donnell, M. Di Rosa, and F.Y. Liew. 1994. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82 (3): 370–375.
- Ialenti, A., A. Ianaro, S. Moncada, and M. Di Rosa. 1992. Modulation of acute inflammation by endogenous nitric oxide. European Journal of Pharmacology 211 (2): 177–182. · DOI · Paper page
- Salvemini, D., Z.Q. Wang, P.S. Wyatt, D.M. Bourdon, M.H. Marino, P.T. Manning, and M.G. Currie. 1996. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118 (4): 829–838. · DOI · Paper page
- Medeiros, M.V., I.M. Binhara, H. Moreno Júnior, R. Zatz, G. De Nucci, and E. Antunes. 1995. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. European Journal of Pharmacology 285 (2): 109–114. · doi:10.1016/0014-2999(95)00332-f
- Toriyabe, M., K. Omote, T. Kawamata, and A. Namiki. 2004. Contribution of interaction between nitric oxide and cyclooxygenases to the production of prostaglandins in carrageenan-induced inflammation. Anesthesiology 101 (4): 983–990. · DOI
- Hughes, S.R., T.J. Williams, and S.D. Brain. 1990. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. European Journal of Pharmacology 191 (3): 481–484. · DOI · Paper page
- Lippe, I.T., A. Stabentheiner, and P. Holzer. 1993. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. European Journal of Pharmacology 232 (1): 113–120. · doi:10.1016/0014-2999(93)90735-z
- Lippe, I.T., A. Stabentheiner, and P. Holzer. 1993. Role of nitric oxide in the vasodilator but not exudative component of mustard oil-induced inflammation in rat skin. Agents Actions 38 Spec No:C22–4. · doi:10.1007/bf01991125
- Benrath, J., C. Eschenfelder, M. Zimmerman, and F. Gillardon. 1995. Calcitonin gene-related peptide, substance P and nitric oxide are involved in cutaneous inflammation following ultraviolet irradiation. European Journal of Pharmacology 293 (1): 87–96. · DOI
- Warren, J.B., R.K. Loi, and M.L. Coughlan. 1993. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. British Journal of Pharmacology 109 (3): 802–806. · DOI
- Chen, Y., M.K. Boettger, A. Reif, A. Schmitt, N. Uçeyler, and C. Sommer. 2010. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Molecular Pain 6: 13.
- Mariani-Pedroso, S.R., L. Bizeto, E. Antunes, R. Zatz, and G. de Nucci. 1995. Dissimilarity between prostaglandin E1 and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo. Prostaglandins Leukotrienes and Essential Fatty Acids 52 (6): 399–402. · doi:10.1016/0952-3278(95)90068-3
- Teixeira, M.M., T.J. Williams, and P.G. Hellewell. 1993. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. British Journal of Pharmacology 110 (4): 1515–1521. · DOI
- Teixeira, M.M., S.M. Fairbairn, K.E. Norman, T.J. Williams, A.G. Rossi, and P.G. Hellewell. 1994. Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: Contribution of neutrophils and endogenous mediators. British Journal of Pharmacology 113 (4): 1363–1371. · doi:10.1111/j.1476-5381.1994.tb17148.x
- Muangman, P., R.N. Tamura, L.A. Muffley, F.F. Isik, J.R. Scott, C. Xie, G. Kegel, S.R. Sullivan, Z. Liang, and N.S. Gibran. 2009. Substance P enhances wound closure in nitric oxide synthase knockout mice. Journal of Surgical Research 153 (2): 201–209. · DOI
- Most, D., D.T. Efron, H.P. Shi, U.S. Tantry, and A. Barbul. 2002. Characterization of incisional wound healing in inducible nitric oxide synthase knockout mice. Surgery. 132 (5): 866–876. · DOI
- Ross, R., C. Gillitzer, R. Kleinz, J. Schwing, H. Kleinert, U. Förstermann, and A.B. Reske-Kunz. 1998. Involvement of NO in contact hypersensitivity. International Immunology 10 (1): 61–69. · DOI
- Orita, K., K. Hiramoto, H. Kobayashi, M. Ishii, A. Sekiyama, and M. Inoue. 2011. Inducible nitric oxide synthase (iNOS) and α-melanocyte-stimulating hormones of iNOS origin play important roles in the allergic reactions of atopic dermatitis in mice. Experimental Dermatology 20 (11): 911–914. · DOI
- Morita, H., M. Hori, and Y. Kitano. 1996. Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide. The Journal of Investigative Dermatology 107 (4): 549–552. · doi:10.1111/1523-1747.ep12582805
- Morita, H., M. Semma, M. Hori, and Y. Kitano. 1995. Clinical application of nitric oxide synthase inhibitor for atopic dermatitis. International Journal of Dermatology 34 (4): 294–295. · doi:10.1111/j.1365-4362.1995.tb01602.x
- Mowbray, M., X. Tan, P.S. Wheatley, A.G. Rossi, R.E. Morris, and R.B. Weller. 2008. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. The Journal of Investigative Dermatology 128 (2): 352–360. · DOI
- Ormerod, A.D., P. Copeland, I. Hay, A. Husain, and S.W. Ewen. 1999. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. The Journal of Investigative Dermatology 113 (3): 392–397. · DOI
- Sugita, K., K. Kabashima, R. Yoshiki, A. Ikenouchi-Sugita, M. Tsutsui, J. Nakamura, N. Yanagihara, and Y. Tokura. 2010. Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival. The Journal of Investigative Dermatology 130 (2): 464–471. · DOI
- Hyun, E., M. Bolla, M. Steinhoff, J.L. Wallace, P.D. Soldato, and N. Vergnolle. 2004. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. British Journal of Pharmacology 143 (5): 618–625. · DOI
- Guttman-Yassky, E., R.L. Gallo, A.B. Pavel, T. Nakatsuji, R. Li, N. Zhang, E. Messersmith, and T. Maeda-Chubachi. 2020. A nitric oxide-releasing topical medication as a potential treatment option for atopic dermatitis through antimicrobial and anti-inflammatory activity. The Journal of Investigative Dermatology 140 (12): 2531-2535.e2. · DOI
- Kuroishi, T., K. Bando, Y. Endo, and S. Sugawara. 2013. Metal allergens induce nitric oxide production by mouse dermal fibroblasts via the hypoxia-inducible factor-2α-dependent pathway. Toxicological Sciences 135 (1): 119–128. · DOI
- Cassini-Vieira, P., F.A. Araújo, F.L. da Costa Dias, R.C. Russo, S.P. Andrade, M.M. Teixeira, and L.S. Barcelos, 2015. iNOS activity modulates inflammation, angiogenesis, and tissue fibrosis in polyether-polyurethane synthetic implants. Mediators Inflammation 2015:138461. · DOI
- Kuchel, J.M., R.S. Barnetson, and G.M. Halliday. 2003. Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans. The Journal of Investigative Dermatology 121 (3): 587–593. · DOI
- Rowe, A., A.M. Farrell, and C.B. Bunker. 1997. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. British Journal of Dermatology 136 (1): 18–23. · doi:10.1111/j.1365-2133.1997.tb08740.x
- Bruch-Gerharz, D., K. Fehsel, C. Suschek, G. Michel, T. Ruzicka, and V. Kolb-Bachofen. 1996. A proinflammatory activity of interleukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. Journal of Experimental Medicine 184 (5): 2007–2012. · DOI · Paper page
- Ormerod, A.D., R. Weller, P. Copeland, N. Benjamin, S.H. Ralston, P. Grabowksi, and R. Herriot. 1998. Detection of nitric oxide and nitric oxide synthases in psoriasis. Archives of Dermatological Research 290 (1–2): 3–8. · DOI
- Sirsjö, A., M. Karlsson, A. Gidlöf, O. Rollman, and H. Törmä. 1996. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. British Journal of Dermatology 134 (4): 643–648. · DOI
- Orem, A., R. Aliyazicioglu, E. Kiran, B. Vanizor, G. Cimnocodeit, and O. Deger. 1997. The relationship between nitric oxide production and activity of the disease in patients with psoriasis. Archives of Dermatology 133 (12): 1606–1607. · doi:10.1001/archderm.133.12.1606
- Paul-Clark, M.J., D.W. Gilroy, D. Willis, D.A. Willoughby, and A. Tomlinson. 2001. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. The Journal of Immunology 166 (2): 1169–1177. · DOI · Paper page
- Iwama, D., S. Miyahara, H. Tamura, K. Miyamoto, F. Hirose, and N. Yoshimura. 2008. Lack of inducible nitric oxide synthases attenuates leukocyte-endothelial cell interactions in retinal microcirculation. British Journal of Ophthalmology 92 (5): 694–698. · DOI
- Sautebin, L., A. Ialenti, A. Ianaro, and M. Di Rosa. 1995. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. European Journal of Pharmacology 286 (2): 219–222. · doi:10.1016/0014-2999(95)00581-5
- Sautebin, L., A. Ialenti, A. Ianaro, and M. Di Rosa. 1995. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. British Journal of Pharmacology 114 (2): 323–328. · DOI
- Paul, W., G.J. Douglas, L. Lawrence, A.M. Khawaja, A.C. Perez, M. Schachter, and C.P. Page. 1994. Cutaneous permeability responses to bradykinin and histamine in the guinea-pig: Possible differences in their mechanism of action. British Journal of Pharmacology 111 (1): 159–164. · DOI
- Andrew, P.J., H. Harant, and I.J. Lindley. 1995. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochemical and Biophysical Research Communications 214 (3): 949–956. · DOI
- Sparkman, L., and V. Boggaram. 2004. Nitric oxide increases IL-8 gene transcription and mRNA stability to enhance IL-8 gene expression in lung epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 287 (4): L764–L773. · DOI
- Kobayashi, Y. 2010. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. Journal of Leukocyte Biology 88 (6): 1157–1162. · DOI · Paper page
- Corriveau, C.C., P.J. Madara, A.L. Van Dervort, M.M. Tropea, R.A. Wesley, and R.L. Danner. 1998. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils. Journal of Infectious Diseases 177 (1): 116–126. · doi:10.1086/513829
- Van Dervort, A.L., L. Yan, P.J. Madara, J.P. Cobb, R.A. Wesley, C.C. Corriveau, M.M. Tropea, and R.L. Danner. 1994. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. The Journal of Immunology 152 (8): 4102–4109. · DOI
- Baig, M.S., S.V. Zaichick, M. Mao, A.L. de Abreu, F.R. Bakhshi, P.C. Hart, U. Saqib, J. Deng, S. Chatterjee, M.L. Block, S.M. Vogel, A.B. Malik, M.E. Consolaro, J.W. Christman, R.D. Minshall, B.N. Gantner, and M.G. Bonini. 2015. NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1. Journal of Experimental Medicine 212 (10): 1725–1738. · DOI
- Niedbala W, B. Cai, and F.Y. Liew. 2006. Role of nitric oxide in the regulation of T cell functions. Annals of the Rheumatic Diseases 65(Suppl 3):iii37–40. · DOI · Paper page
- Granger, D.N., and P. Kubes. 1996. Nitric oxide as antiinflammatory agent. Methods in Enzymology 269: 434–442. · DOI
- Gaboury, J., R.C. Woodman, D.N. Granger, P. Reinhardt, and P. Kubes. 1993. Nitric oxide prevents leukocyte adherence: Role of superoxide. American Journal of Physiology 265 (3 Pt 2): H862–H867.
- Kubes, P., I. Kurose, and D.N. Granger. 1994. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. American Journal of Physiology 267 (3 Pt 2): H931–H937.
- Wallace, J.L., N. Vergnolle, M.N. Muscará, S. Asfaha, K. Chapman, W. McKnight, P. Del Soldato, A. Morelli, and S. Fiorucci. 1999. Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology 117 (3): 557–566. · DOI
- Qin, M., A. Landriscina, J.M. Rosen, G. Wei, S. Kao, W. Olcott, G.W. Agak, K.B. Paz, J. Bonventre, A. Clendaniel, S. Harper, B.L. Adler, A.E. Krausz, J.M. Friedman, J.D. Nosanchuk, J. Kim, and A.J. Friedman. 2015. Nitric oxide-releasing nanoparticles prevent Propionibacterium acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. The Journal of Investigative Dermatology 135 (11): 2723–2731. · DOI
- Qin, M., A. Pirouz, M.H. Kim, S.R. Krutzik, H.J. Garbán, and J. Kim. 2014. Propionibacterium acnes induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. The Journal of Investigative Dermatology 134 (2): 381–388. · DOI · Paper page
- Bauernfeind, F.G., G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B.G. Monks, K.A. Fitzgerald, V. Hornung, and E. Latz. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. The Journal of Immunology 183 (2): 787–791. · DOI · Paper page
- Kistowska, M., S. Gehrke, D. Jankovic, K. Kerl, A. Fettelschoss, L. Feldmeyer, G. Fenini, A. Kolios, A. Navarini, R. Ganceviciene, J. Schauber, E. Contassot, and L.E. French. 2014. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo. The Journal of Investigative Dermatology 134 (3): 677–685. · DOI · Paper page
- Li, Z.J., D.K. Choi, K.C. Sohn, M.S. Seo, H.E. Lee, Y. Lee, Y.J. Seo, Y.H. Lee, G. Shi, C.C. Zouboulis, C.D. Kim, J.H. Lee, and M. Im. 2014. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. The Journal of Investigative Dermatology 134 (11): 2747–2756. · DOI
- Hernandez-Cuellar, E., K. Tsuchiya, H. Hara, R. Fang, S. Sakai, I. Kawamura, S. Akira, and M. Mitsuyama. 2012. Cutting edge: Nitric oxide inhibits the NLRP3 inflammasome. The Journal of Immunology 189 (11): 5113–5117. · DOI · Paper page
- Wishah, K., A. Malur, B. Raychaudhuri, A.L. Melton, M.S. Kavuru, and M.J. Thomassen. 2002. Nitric oxide blocks inflammatory cytokine secretion triggered by CD23 in monocytes from allergic, asthmatic patients and healthy controls. Annals of Allergy, Asthma & Immunology 89 (1): 78–82. · DOI
- Dinakar, C., A. Malur, B. Raychaudhuri, L.T. Buhrow, A.L. Melton, M.S. Kavuru, and M.J. Thomassen. 1999. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Annals of Allergy, Asthma & Immunology 82 (2): 217–222. · DOI
- Persoons, J.H., K. Schornagel, F.F. Tilders, J. De Vente, F. Berkenbosch, and G. Kraal. 1996. Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide. American Journal of Respiratory Cell and Molecular Biology 14 (3): 272–278. · doi:10.1165/ajrcmb.14.3.8845178
- Qiu, H.B., D.C. Chen, J.Q. Pan, D.W. Liu, and S. Ma. 1999. Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages. Zhongguo Yao Li Xue Bao 20 (3): 271–275.
- Deakin, A.M., A.N. Payne, B.J. Whittle, and S. Moncada. 1995. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 7 (5): 408–416. · DOI
- Yu, C., A. Fitzpatrick, D. Cong, C. Yao, J. Yoo, A. Turnbull, J. Schwarze, M. Norval, S.E.M. Howie, R.B. Weller, and A.L. Astier. 2017. Nitric oxide induces human CLA+CD25+Foxp3+ regulatory T cells with skin-homing potential. The Journal of Allergy and Clinical Immunology 140 (5): 1441-1444.e6. · DOI
- Allione, A., P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli. 1999. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. The Journal of Immunology 163 (8): 4182–4191. · DOI
- Ialenti, A., A. Ianaro, P. Maffia, L. Sautebin, and M. Di Rosa. 2000. Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflammation Research 49 (8): 411–417. · DOI
- Dal Secco, D., A.P. Moreira, A. Freitas, J.S. Silva, M.A. Rossi, S.H. Ferreira, and F.Q. Cunha. 2006. Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: Role of soluble guanylate cyclase. Nitric Oxide 15 (1): 77–86. · DOI
- Vallance, P., and A. Hingorani. 1999. Endothelial nitric oxide in humans in health and disease. International Journal of Experimental Pathology 80 (6): 291–303. · DOI
- Armstrong, R. 2001. The physiological role and pharmacological potential of nitric oxide in neutrophil activation. International Immunopharmacology 1 (8): 1501–1512. · DOI
- Tripathi, P. 2007. Nitric oxide and immune response. Indian Journal of Biochemistry & Biophysics 44 (5): 310–319.
- Coleman, J.W. 2002. Nitric oxide: A regulator of mast cell activation and mast cell-mediated inflammation. Clinical and Experimental Immunology 129 (1): 4–10. · DOI · Paper page
Cited by
ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways
de Almeida, A. J. P. O., de Oliveira, J. C. P. L., da Silva Pontes, L. V., de Souza Júnior, J. F., Gonçalves, T. A. F., Dantas, S. H., de Almeida Feitosa, M. S., Silva, A. O., & de Medeiros, I. A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1225578 · Cited by 474
Dumitru, C. D., Ilie, C.-I., Neacsu, I. A., Motelica, L., Oprea, O. C., Ripszky, A., Pițuru, S. M., Voicu Bălașea, B., Marinescu, F., & Andronescu, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146809 · Cited by 33
Tampa, M., Nicolae, I., Ene, C. D., Mitran, C. I., Mitran, M. I., Matei, C., & Georgescu, S. R. (2024) · Antioxidants · doi:10.3390/antiox13060670 · Cited by 8
“The exact mechanisms underlying the dual effects of NO on cutaneous inflammation are not fully understood, needing further investigation [43].”
Background
Metadata
- Authors
- Man, M.-Q., Wakefield, J. S., Mauro, T. M., & Elias, P. M.
- ORCID
- Man, Mao-Qiang
- Venue
- Inflammation
- Published
- 2022-01-30
- Volume
- 45
- Issue
- 3
- Pages
- 949-964
- ISSN
- 0360-3997
- 1573-2576
- Cited by
- 98
- References
- 4
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061106)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulatory Role of Nitric Oxide in Cutaneous Inflammation. https://app.cochat.ai/papers/10.1007/s10753-021-01615-8
- The paper
- Man, M.-Q., Wakefield, J. S., Mauro, T. M., & Elias, P. M. (2022). Regulatory Role of Nitric Oxide in Cutaneous Inflammation. Inflammation. https://doi.org/10.1007/s10753-021-01615-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.